Akoya Biosciences, Inc.
Total Trades
35
Buys
7
Sells
18
Largest Trade
$1M+
Insiders
11
Institutional Funds
15
Inst. Value
$1M+
Activist Filings
15
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| McKelligon Brian | President and CEO | SELL | $15K–$50K | 8K | $2.08 | Jun 12, 2024 |
| McKelligon Brian | President and CEO | EXERCISE | $1K–$15K | 8K | $0.30 | Jun 12, 2024 |
| McKelligon Brian | President and CEO | SELL | $15K–$50K | 8K | $2.01 | Jun 8, 2024 |
| McKelligon Brian | President and CEO | EXERCISE | $1K–$15K | 8K | $0.30 | Jun 8, 2024 |
| McKelligon Brian | President and CEO | EXERCISE | $1K–$15K | 8K | $0.30 | Mar 22, 2024 |
| McKelligon Brian | President and CEO | SELL | $15K–$50K | 8K | $4.97 | Mar 22, 2024 |
| McKelligon Brian | President and CEO | EXERCISE | $1K–$15K | 8K | $0.30 | Nov 22, 2023 |
| McKelligon Brian | President and CEO | SELL | $15K–$50K | 8K | $4.39 | Nov 22, 2023 |
| Pla Frederic | COO | BUY | $50K–$100K | 20K | $4.60 | Sep 11, 2023 |
| Ek John Frederick | CFO | BUY | $100K–$500K | 20K | $5.00 | Jun 12, 2023 |
| LAI GOLDMAN MYLA | Director | BUY | $100K–$500K | 20K | $5.00 | Jun 12, 2023 |
| Mendel Scott | Director | BUY | $100K–$500K | 20K | $5.00 | Jun 12, 2023 |
| Winkler Matthew | Director | BUY | $1M+ | 203K | $5.00 | Jun 12, 2023 |
| SHEPLER ROBERT G | Director | BUY | $500K+ | 120K | $5.00 | Jun 12, 2023 |
| Raffin Thomas A. | Director | BUY | $1M+ | 2.0M | $5.00 | Jun 12, 2023 |
| McKelligon Brian | President/CEO | EXERCISE | $1K–$15K | 5K | $0.30 | Jun 7, 2023 |
| McKelligon Brian | President/CEO | SELL | $15K–$50K | 5K | $5.71 | Jun 7, 2023 |
| McKelligon Brian | President/CEO | SELL | $15K–$50K | 5K | $9.17 | Mar 16, 2023 |
| McKelligon Brian | President/CEO | EXERCISE | $1K–$15K | 5K | $0.30 | Mar 16, 2023 |
| SCHNETTLER THOMAS P | Director | SELL | $500K+ | 71K | $13.03 | Dec 20, 2022 |
| DRISCOLL JOSEPH | CFO | SELL | $100K–$500K | 25K | $12.54 | Dec 16, 2022 |
| DRISCOLL JOSEPH | CFO | EXERCISE | $1K–$15K | 25K | $0.44 | Dec 16, 2022 |
| Nolan Garry Ph.D. | Director | SELL | $1K–$15K | 100 | $13.25 | Dec 16, 2022 |
| McKelligon Brian | President/CEO | EXERCISE | $1K–$15K | 5K | $0.30 | Dec 8, 2022 |
| McKelligon Brian | President/CEO | SELL | $50K–$100K | 5K | $12.08 | Dec 8, 2022 |
| Nolan Garry Ph.D. | Director | SELL | $1K–$15K | 1K | $13.25 | Dec 6, 2022 |
| Nolan Garry Ph.D. | Director | SELL | $50K–$100K | 5K | $13.36 | Dec 2, 2022 |
| Nolan Garry Ph.D. | Director | SELL | $1K–$15K | 300 | $13.25 | Nov 17, 2022 |
| Nolan Garry Ph.D. | Director | SELL | $100K–$500K | 24K | $13.29 | Nov 14, 2022 |
| Nolan Garry Ph.D. | Director | SELL | $100K–$500K | 8K | $13.26 | Sep 16, 2022 |
| Nolan Garry Ph.D. | Director | SELL | $100K–$500K | 24K | $13.31 | Sep 13, 2022 |
| McKelligon Brian | President/CEO | SELL | $50K–$100K | 5K | $12.83 | Sep 9, 2022 |
| McKelligon Brian | President/CEO | EXERCISE | $1K–$15K | 5K | $0.30 | Sep 9, 2022 |
| McKelligon Brian | President/CEO | SELL | $50K–$100K | 5K | $10.25 | Jun 17, 2022 |
| McKelligon Brian | President/CEO | EXERCISE | $1K–$15K | 5K | $0.30 | Jun 17, 2022 |
Institutional Ownership
13F filings as of Jun 30, 2025 · 15 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| PEDDOCK CAPITAL ADVISORS, LLC | 235K | $100K–$500K | SH |
| JANE STREET GROUP, LLC | 177K | $100K–$500K | SH |
| CREDIT INDUSTRIEL ET COMMERCIAL | 170K | $100K–$500K | SH |
| MILLENNIUM MANAGEMENT LLC | 92K | $100K–$500K | SH |
| ZWJ INVESTMENT COUNSEL INC | 48K | $50K–$100K | SH |
| Vanguard Personalized Indexing Management, LLC | 29K | $15K–$50K | SH |
| TRANSCEND CAPITAL ADVISORS, LLC | 28K | $15K–$50K | SH |
| Y-Intercept (Hong Kong) Ltd | 26K | $15K–$50K | SH |
| Tower Research Capital LLC (TRC) | 16K | $15K–$50K | SH |
| Callan Family Office, LLC | 10K | $1K–$15K | SH |
| MORGAN STANLEY | 3K | $1K–$15K | SH |
| CWM, LLC | 2K | $1K–$15K | SH |
| RAYMOND JAMES FINANCIAL INC | 1K | $1K–$15K | SH |
| ROYAL BANK OF CANADA | 706 | $1K–$15K | SH |
| NISA INVESTMENT ADVISORS, LLC | 594 | <$1K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13D/A · Apr 30, 2025
55.6%
30.6M shares
SC 13D · Jan 16, 2025
55.9%
27.7M shares
SC 13G/A · Nov 4, 2024
9.4%
4.7M shares
Blue Water Life Science Advisors, LP
SC 13G · Aug 28, 2024
9.6%
4.7M shares
Telegraph Hill Partners III, L.P.
SC 13G/A · Feb 14, 2024
36.0%
17.7M shares
SC 13G/A · Feb 12, 2024
7.2%
3.5M shares
SC 13G/A · Jan 3, 2024
5.8%
2.9M shares
SC 13G · Jun 13, 2023
5.2%
2.5M shares
SC 13G/A · Feb 15, 2023
7.2%
2.7M shares
SC 13G/A · Feb 14, 2023
7.2%
2.7M shares
SC 13D/A · Dec 2, 2022
6.4%
2.4M shares
SC 13D/A · Sep 13, 2022
9.8%
3.7M shares
SC 13G · Feb 25, 2022
7.6%
2.8M shares
Telegraph Hill Partners III, L.P.
SC 13G/A · Feb 14, 2022
42.1%
15.7M shares
SC 13G · Feb 14, 2022
7.6%
2.8M shares